18F-FDG PET/CT versus CT imaging in staging of primary Muscle Invasive Bladder Cancer - MIBC PETCT

eids Universitair Medisch Centrum0 个研究点目标入组 120 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•-All patients with a clinical diagnosis of muscle invasive bladder cancer with active disease identified within the bladder at the time of consent and imaging.
•-Patients with primary resectable tumour in the bladder, clinically suspect of invasive bladder carcinoma, who are potential candidates for radical cystectomy plus lymphadenectomy, will be eligible with residual disease in the bladder at the time of imaging.
•-All patients will have consented to diagnostic imaging procedures.

•- Prior biopsy of the primary bladder tumour within 6 months before PET/CT imaging
•- Prior BCG instillations.
•- Treatment with bladder instillations other than with BCG less than 6 months ago
•- Patients with sarcoidosis, tuberculosis and/or lymphatic disorders
•* Prior pelvic radiation for bladder cancer
•- Patients deemed not appropriate surgical candidates
•- Patients that cannot tolerate being in the PET scanner or deemed unable to receive a contrast enhanced CT.
•- Patients who are pregnant or lactating

发起方